Aβ plaque-associated glial reaction as a determinant of apoptotic neuronal death and cortical gliogenesis: A study in APP mutant mice

Neuroscience Letters

Volumn 506, Issue 1, 2012, Pages 94-99

  Luccarini, Ilaria ^a   Grossi, Cristina ^a   Traini, Chiara ^a   Fiorentini, Anna ^a   Ed Dami, Teresa ^a   Casamenti, Fiorella ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Alzheimer's disease; Apoptosis; Cortical gliogenesis; Neuroinflammation; TgCRND8 mouse model

Indexed keywords

AMYLOID BETA PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; PROTEIN BAX; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA;

AMYLOID PLAQUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GLIA CELL; HIPPOCAMPUS; IMMUNOREACTIVITY; INFLAMMATION; MALE; MICROGLIA; MOUSE; NEOCORTEX; NERVE CELL DIFFERENTIATION; NERVE CELL NECROSIS; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AGE FACTORS; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; APOPTOSIS; BROMODEOXYURIDINE; CALCIUM-BINDING PROTEINS; CELL PROLIFERATION; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MICE; MICE, TRANSGENIC; MICROFILAMENT PROTEINS; MUTATION; NEUROGLIA; NEURONS; NITRIC OXIDE SYNTHASE TYPE II; PLAQUE, AMYLOID;

EID: 84855199741     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.10.056     Document Type: Article

References (30)

1. Baldwin A.S. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 1996, 14:649-683.
2. Bellucci A., Luccarini I., Scali C., Prosperi C., Giovannini M.G., Casamenti F., Pepeu G. Cholinergic dysfunction, neuronal damage and axonal loss in TgCRND8 mice. Neurobiol. Dis. 2006, 165:1643-1652.
3. Bellucci A., Rosi M.C., Grossi C., Fiorentini A., Luccarini I., Casamenti F. Abnormal processing of tau in the brain of aged TgCRND8 mice. Neurobiol. Dis. 2007, 27:328-338.
4. Bondolfi L., Calhoun M., Ermini F., Kuhn H.G., Wiederhold K.H., Walker L., Staufenbiel M., Jucker M. Amyloid-associated neuron loss and gliogenesis in the neocortex of amyloid precursor protein transgenic mice. J. Neurosci. 2002, 22:515-522.
5. Chishti M.A., Yang D.S., Janus C., Phinney A.L., Horne P., Pearson J., Strome R., Zuker N., Loukides J., French J., Turner S., Lozza G., Grilli M., Kunicki S., Morissette C., Paquette J., Gervais F., Bergeron C., Fraser P.E., Carlson G.A., George-Hyslop P.S., Westaway D. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J. Biol. Chem. 2001, 276:21562-21570.
6. Czeh B., Lucassen P.J. What causes the hippocampal volume decrease in depression? Are neurogenesis, glial changes and apoptosis implicated?. Eur. Arch. Psychiatry Clin. Neurosci. 2007, 257:250-260.
7. Ehninger D., Kempermann G. Regional effects of wheel running and environmental enrichment on cell genesis and microglia proliferation in the adult murine neocortex. Cereb. Cortex 2003, 13:845-851.
8. Ekdahl C.T., Kokaia Z., Lindvall O. Brain inflammation and adult neurogenesis: the dual role of microglia. Neuroscience 2009, 158:1021-1029.
9. Fernandez-Vizarra P., Fernandez A.P., Castro-Blanco S., Encinas J.M., Serrano J., Bentura M.L., Munoz P., Martinez-Murillo R., Rodrigo J. Expression of nitric oxide system in clinically evaluated cases of Alzheimer's disease. Neurobiol. Dis. 2004, 15:287-305.
10. Fiorentini A., Rosi M.C., Grossi C., Luccarini I., Casamenti F. Lithium improves hippocampal neurogenesis, neuropathology and cognitive functions in APP mutant mice. PLoS One 2010, 5:e14382.
11. Helfer J.L., Calizo L.H., Dong W.K., Goodlett C.R., Greenough W.T., Klintsova A.Y. Binge-like postnatal alcohol exposure triggers cortical gliogenesis in adolescent rats. J. Comp. Neurol. 2009, 514:259-271.
12. Ihnatko R., Kubes M. TNF signaling: early events and phosphorylation. Gen. Physiol. Biophys. 2007, 26:159-167.
13. Kaltschmidt B., Baeuerle P.A., Kaltschmidt C. Potential involvement of the transcription factor NF-kappa B in neurological disorders. Mol. Aspects Med. 1993, 14:171-190.
14. Kodama M., Fujioka T., Duman R.S. Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat. Biol. Psychiatry 2004, 56:570-580.
15. Kornack D.R., Rakic P. Cell proliferation without neurogenesis in adult primate neocortex. Science 2001, 294:2127-2130.
16. Laflamme N., Rivest S. Effects of systemic immunogenic insults and circulating proinflammatory cytokines on the transcription of the inhibitory factor kappaB alpha within specific cellular populations of the rat brain. J. Neurochem. 1999, 73:309-321.
17. Magavi S.S., Leavitt B.R., Macklis J.D. Induction of neurogenesis in the neocortex of adult mice. Nature 2000, 405:951-955.
18. Magavi S.S., Macklis J.D. Induction of neuronal type-specific neurogenesis in the cerebral cortex of adult mice: manipulation of neural precursors in situ. Brain Res. Dev. Brain Res. 2002, 134:57-76.
19. Mattson M.P., Camandola S. NF-kappaB in neuronal plasticity and neurodegenerative disorders. J. Clin. Invest. 2001, 107:247-254.
20. McGeer P.L., McGeer E.G. Local neuroinflammation and the progression of Alzheimer's disease. J. Neurovirol. 2002, 8:529-538.
21. Munhoz C.D., Garcia-Bueno B., Madrigal J.L., Lepsch L.B., Scavone C., Leza J.C. Stress-induced neuroinflammation: mechanisms and new pharmacological targets. Braz. J. Med. Biol. Res. 2008, 41:1037-1046.
22. O'Neill L.A., Kaltschmidt C. NF-kappa B: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 1997, 20:252-258.
23. Pannu R., Singh I. Pharmacological strategies for the regulation of inducible nitric oxide synthase: neurodegenerative versus neuroprotective mechanisms. Neurochem. Int. 2006, 49:170-182.
24. Park K.J., Lee S.H., Kim T.I., Lee H.W., Lee C.H., Kim E.H., Jang J.Y., Choi K.S., Kwon M.H., Kim Y.S. A human scFv antibody against TRAIL receptor 2 induces autophagic cell death in both TRAIL-sensitive and TRAIL-resistant cancer cells. Cancer Res. 2007, 67:7327-7334.
25. Perry G., Raina A.K., Nunomura A., Wataya T., Sayre L.M., Smith M.A. How important is oxidative damage? Lessons from Alzheimer's disease. Free Radic. Biol. Med. 2000, 28:831-834.
26. Perry S.W., Dewhurst S., Bellizzi M.J., Gelbard H.A. Tumor necrosis factor-alpha in normal and diseased brain: conflicting effects via intraneuronal receptor crosstalk?. J. Neurovirol. 2002, 8:611-624.
27. Rodrigo J., Fernandez-Vizarra P., Castro-Blanco S., Bentura M.L., Nieto M., Gomez-Isla T., Martinez-Murillo R., MartInez A., Serrano J., Fernandez A.P. Nitric oxide in the cerebral cortex of amyloid-precursor protein (SW) Tg2576 transgenic mice. Neuroscience 2004, 128:73-89.
28. Rosi M.C., Luccarini I., Grossi C., Fiorentini A., Spillantini M.G., Prisco A., Scali C., Gianfriddo M., Caricasole A., Terstappen G.C., Casamenti F. Increased Dickkopf-1 expression in transgenic mouse models of neurodegenerative disease. J. Neurochem. 2010, 112:1539-1551.
29. Selkoe D.J. Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J. Alzheimers Dis. 2001, 3:75-80.
30. Sundholm-Peters N.L., Yang H.K., Goings G.E., Walker A.S., Szele F.G. Subventricular zone neuroblasts emigrate toward cortical lesions. J. Neuropathol. Exp. Neurol. 2005, 64:1089-1100.